ኢንስቲትዩቱ ባለፉት አስር ወራት ወደ ተለያዩ የአፍሪካ አገራት ከላከው የእንስሳት ክትባት 800 ሺህ ዶላር ገቢ አገኘ

ብሔራዊ የእንስሳት ጤና ጥበቃ ኢንስቲትዩት ባለፉት አስር ወራት ወደ ተለያዩ የአፍሪካ አገራት ከላከው የእንስሳት ክትባት 800 ሺህ ዶላር ገቢ አገኘ

ክቡር አምባሳደር ድሪባ ኩማ፣ የኢትዮጵያ ግብርና ባለስልጣን ዋና ዳይሬክተር እና የባለስልጣን መስሪያ ቤቱ የስራ ሃላፊዎች ኢንስቲትዩቱን ጎበኙ

የኢትዮጵያ ግብርና ባለስልጣን ዋና ዳይሬክተር ክቡር አምባሳደር ድሪባ ኩማ እና ሌሎች የባለስልጣን መስሪያቤቱ የስራ ሃላፊዎች በብሔራዊ የእንሰሳት ጤና ጥበቃ ኢንስቲትዩት ጳጉሜ 4 ቀን 2014 ዓ.ም የስራ ጉብኝት አደረጉ፡፡

በብሔራዊ የእንሰሳት ጤና ጥበቃ ኢንስቲትዩት በደንበኞች ቀን የክልል ባለድርሻ አካላት ዉይይት አደረጉ

ኢንስቲትዩቱ ስትራቴጂካዊ ግቦችን ለማሳካትና የደንበኛ እርካታን ለማሳደግ እንዲሁም የተቋቋመበትን ዋና አላማ፡- ጥራት ያላቸዉ እና በምርምር የተደገፉ የእንሰሳት ክትባቶች እና መድሃኒቶችን በሚፈለገዉ ጊዜ አምርቶ ለተጠቃሚዉ ለማድረስ ያስችለዉ ዘንድ

የመንግስት የልማት ድርጅቶች ይዞታዎችና አስተዳደር የስራ አመራር አባላት በብሔራዊ የእንሰሳት ጤና ጥበቃ ኢንስቲትዩት የስራ ጉብኝት አደረጉ

ኢንስቲትዩቱ የእንሰሳት ሀብት ዘርፉን ለመደገፍ ለእንሰሳት ጤና ጥበቃ የሚያገለግሉ ግብአቶችን እንዲያመርት በተሰጠዉ ተልዕኮ መሰረት በምርምር የተደገፉ 23 አይነት የእንሰሳት በሽታ መከላከያ ክትባቶችን ፣ የእንሰሳት በሽታ መመርመሪያ የሚያገለግሉ ባዮሎጂካሎችን እንዲሁም በ2013 ዓ.ም የእንሰሳት መድሃኒት ማቀነባበሪያ ፋብሪካ ተመርቆ 12 አይነት የእንሰሳት መድሃኒት ለማምረት ታቅዶ  ወደ ምርት መገባቱን የገለጹት በዕለቱ ስለ ተቋሙ መግለጫRead More

National Veterinary Institute Recognized for its contribution to the eradication of Rinderpest

The African Union-InterAfrican Bureau for Animal Resources (AU-IBAR) has recognized the National Veterinary Institute (NVI) for its significant contribution towards assuring the quality of vaccines used in the eradication of Rinderpest in Africa (1985-2000) on AU-IBAR 70th Anniversary and 10th Anniversary of Rinderpest eradication on 18th march 2022 Nairobi, Kenya.

Inauguration of the Nation’s Pioneer Veterinary Drug Manufacturing Plant

The National Veterinary Institute (NVI) was established in 1964 under the then the Ministry of Agriculture with the objective of producing different vaccines to protect animals from various infectious diseases. The institute again reorganized as a public enterprise in 1999 by the Council of ministers under the proclamation No 25/1992 and Regulations No. 52/1999 with the mandates of production of veterinary vaccines and drugs.

The NVI supports testing COVID-19 in Ethiopia

With the occurrence of the COVID-19 pandemic crisis worldwide, veterinary laboratories in many parts of the world have been taking part in the diagnosis of COVID-19 using the technical expertise and the diagnostic facilities they have through one-health coordinated approaches. The National Veterinary Institute (NVI) of Ethiopia is supporting theRead More

A non-replicative adenovirus vaccine platform for poultry diseases

Poultry are a vital village livestock asset and are particularly important for the economic independence of women in sub-Saharan Africa (SSA). In times of financial crisis, poultry become the most critical livestock asset due to their versatility and independence. Newcastle disease (ND) is one of the most critical poultry diseasesRead More

Engineering a vaccine against hemorrhagic septicemia

The challenge Hemorrhagic septicemia, caused by the bacteria Pasteurella multocida, is an acute and often fatal bacterial disease that primarily affects cattle and buffaloes in Asian and African countries. Most Asian countries rank hemorrhagic septicemia as the most significant contagious disease in cattle and buffaloes. Globally, the disease is the secondRead More

Workshop on technology transfer underway in the NVI

Workshop targeting technology transfers on recombinant veterinary vaccines development and production is underway in the National Veterinary Institute for three days (16-18 December 2019) here in our country, Bishoftu-Ethiopia. The workshop bring together the main players and professionals in vaccine technology from different countries of Canada-McGill university, Tunisia-Institute Pasteur desRead More